跳到主要內容

肯尼斯·I·凱廷的文章

健康2011年8月1日

新藥匱乏

治療神經精神疾病的藥物對於大型製藥公司而言風險過高

肯尼斯·I·凱廷, 克里斯托弗·P·米爾恩

Expand Your World with Science

Learn and share the most exciting discoveries, innovations and ideas shaping our world today.

Subscribe Sign up for our newsletters See the latest stories Read the latest issue Give a Gift Subscription

Follow Us:

Return & Refund Policy
About
Press Room

FAQs
Contact Us
International Editions

Advertise
Accessibility Statement
Terms of Use

Privacy Policy
California Consumer Privacy Statement
Use of cookies/Do not sell my data

大眾科學 is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www.springernature.com/us). 大眾科學 maintains a strict policy of editorial independence in reporting developments in science to our readers.

© 2024 大眾科學, A DIVISION OF SPRINGER NATURE AMERICA, INC.
ALL RIGHTS RESERVED.

© .